Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03252145 · ClinicalTrials.gov registry record · NA
Treatment of Breast Cancer-related Lymphedema With a Negative Pressure Device
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03252145 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 28 participants.
The verdict
NCT03252145, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
This study will be a 4 to 6 week randomized, controlled, assessor blinded, trial comparing a negative pressure massage device (intervention group), to the standard manual lymph drainage massage (control group), in breast cancer patients with chronic upper extremity lymphedema.
Interventions
- DEVICE PhysioTouch
- OTHER Manual Lymph Drainage (MLD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2017-10-31 |
| Est. Completion | 2020-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03252145
The ClinicalTrials.gov registry entry for NCT03252145 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PhysioTouch is the first listed.
NCT03252145 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03252145 about?
NCT03252145 is a clinical study titled "Treatment of Breast Cancer-related Lymphedema With a Negative Pressure Device". This study will be a 4 to 6 week randomized, controlled, assessor blinded, trial comparing a negative pressure massage device (intervention group), to the standard manual lymph drainage massage (control group), in breast cancer patients with chronic upper extremity lymphedema.
What is the current status of trial NCT03252145?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2017-10-31. Estimated completion is 2020-01-31.
What interventions are being tested in trial NCT03252145?
The interventions under investigation include: PhysioTouch (DEVICE), Manual Lymph Drainage (MLD) (OTHER).
Who is sponsoring clinical trial NCT03252145?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.